Cargando…
Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
Autores principales: | Huang, Hongyan, He, Meifang, Zhang, Yanbin, Zhang, Bo, Niu, Zubiao, Zheng, You, Li, Wen, Cui, Peilin, Wang, Xiaoning, Sun, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576137/ https://www.ncbi.nlm.nih.gov/pubmed/33082315 http://dx.doi.org/10.1038/s41392-020-00346-w |
Ejemplares similares
-
Fluorescence-Activated Cell Sorting Analysis of Heterotypic Cell-in-Cell Structures
por: He, Meifang, et al.
Publicado: (2015) -
Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
por: Shimagaki, Tomonari, et al.
Publicado: (2023) -
Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2019) -
Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023) -
Biomarkers as Predictors of Recurrence following Curative Resection for Pancreatic Ductal Adenocarcinoma: A Review
por: Osayi, Sylvester N., et al.
Publicado: (2014)